Evidence map›Paper›PMID 42157812›Full record

ArticleACS medicinal chemistry letters2026

Computer-Aided Design of

Raquel M Quigua Orozco, Alexandre D O Santos, Joelma P Rossetto, Elisângela S Madalozzo, Lívia V Luchi, Samilla B Rezende, Lai Yue Chan, Danieli F Buccini, Maria L R Macedo, Angela Mehta and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Raquel M Quigua OrozcoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.ORCID https://orcid.org/0000-0003-1795-8277
Alexandre D O SantosS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
Joelma P RossettoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
Elisângela S MadalozzoUniversidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Lívia V LuchiS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
Samilla B RezendeS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
Lai Yue ChanInstitute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane 4072, Australia.ORCID https://orcid.org/0000-0002-9346-2487
Danieli F BucciniS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
Maria L R MacedoLaboratório de Purificação de Proteínas e suas Funções Biológicas, Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Angela MehtaEmbrapa Recursos Genéticos e Biotecnologia, Brasília 70.770-917, Brazil.
David J CraikInstitute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane 4072, Australia.ORCID https://orcid.org/0000-0003-0007-6796
Octávio L FrancoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.ORCID https://orcid.org/0000-0001-9546-0525
Marlon H CardosoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia,Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.ORCID https://orcid.org/0000-0001-6676-5362

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in computational design have greatly accelerated antimicrobial peptide engineering. In this study, three

Indexed as

Antimicrobial peptidesbiofilm inhibitiondrug designimmunomodulatory activity

Identifiers

PMID42157812
PMCPMC13181477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.